AbbVie (ABBV) Revenue — Quarter Ended Mar 31, 2023
Revenue declined from the preceding quarter and from the same quarter a year earlier. The drop continued the downward trend visible in recent quarters.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue declined from the preceding quarter and from the same quarter a year earlier. The drop continued the downward trend visible in recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$12.2B
Revenue reported for this quarter.
Quarter-over-quarter
-19.2%
Change from the immediately preceding quarter.
Year-over-year
-9.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$56.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $14.6B | +4.5% |
| Sep 30, 2022 | $14.8B | +3.3% |
| Dec 31, 2022 | $15.1B | +1.6% |
| Mar 31, 2023 | $12.2B | -9.7% |
Revenue performance
Reported revenue fell sharply compared to both the prior quarter and the year-ago period.
Quarterly comparison
Compared to the immediately preceding quarter, revenue decreased, and versus the same quarter one year earlier, revenue also fell.
What to watch
Monitor whether the revenue decline stabilizes in subsequent filings.